Exact Mass: 688.3094758

Exact Mass Matches: 688.3094758

Found 82 metabolites which its exact mass value is equals to given mass value 688.3094758, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Halistanol sulfate

[(2S,3S,5S,6S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-2,3-disulfooxy-17-[(2R,5S)-5,6,6-trimethylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] hydrogensulfate

C29H52O12S3 (688.2620751999999)


   

2-O-sulfo-2-stearoyl-alpha,alpha-trehalose

2-O-sulfo-2-stearoyl-alpha,alpha-trehalose

C30H56O15S (688.3339746)


   

Encequidar

N-[2-(2-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]phenyl}-2H-1,2,3,4-tetrazol-5-yl)-4,5-dimethoxyphenyl]-4-oxo-4H-chromene-2-carboxamide

C38H36N6O7 (688.2645345999999)


   
   
   
   

4-O-methylbutin-7-O-[(6->1)-3,11-dimethyl-7-hydroxymethylenedodecanyl]-beta-D-glucopyranoside

4-O-methylbutin-7-O-[(6->1)-3,11-dimethyl-7-hydroxymethylenedodecanyl]-beta-D-glucopyranoside

C37H52O12 (688.3458592)


   
   
   
   
   
   
   
   

aeruginosin DA642B|D-o-Cl-Hpla-D-Leu-L-Choi-6-sulfate-agmatine

aeruginosin DA642B|D-o-Cl-Hpla-D-Leu-L-Choi-6-sulfate-agmatine

C29H45ClN6O9S (688.2657110000001)


   
   
   

rel-(4aR,6R,6aR,7S,8S,10R,11aR,12R,12aS,12bR)-5,6,6a,7,8,10,11a,12,12a-decahydro-11a-(1-hydroxy-1-methylethyl)-3,3,6a,9-tetramethyl-1H-azuleno[5,5-f][1,3]benzodioxin-6,7,8,10,12,12b(4aH)-hexol 6,7,12-triacetate 8-benzoate|sumataxin C

rel-(4aR,6R,6aR,7S,8S,10R,11aR,12R,12aS,12bR)-5,6,6a,7,8,10,11a,12,12a-decahydro-11a-(1-hydroxy-1-methylethyl)-3,3,6a,9-tetramethyl-1H-azuleno[5,5-f][1,3]benzodioxin-6,7,8,10,12,12b(4aH)-hexol 6,7,12-triacetate 8-benzoate|sumataxin C

C36H48O13 (688.3094758)


   
   

furost-25(27)-en-1beta,2beta,3beta,4beta,5beta,7alpha,22,26-octaol-6-one 26-O-beta-D-glucopyranoside

furost-25(27)-en-1beta,2beta,3beta,4beta,5beta,7alpha,22,26-octaol-6-one 26-O-beta-D-glucopyranoside

C33H52O15 (688.3306042)


   

30,30,34,34-tetrachlorocylindrocyclophane F|cylindrocyclophane F4

30,30,34,34-tetrachlorocylindrocyclophane F|cylindrocyclophane F4

C36H52Cl4O4 (688.2619512)


   
   

N, N, N-Disinapoyl, p-coumaroylagmatine

N, N, N-Disinapoyl, p-coumaroylagmatine

C36H40N4O10 (688.27443)


   
   

4-tert-Butylcalix[5]arene-crown-5-complex

4-tert-Butylcalix[5]arene-crown-5-complex

C43H44O8 (688.3036024)


   

N,N,N,N-Tetra(2-naphthyl)-4,4-biphenyldiamine

N,N,N,N-Tetra(2-naphthyl)-4,4-biphenyldiamine

C52H36N2 (688.2878336)


   

(R)-Xylyl-PHANEPhos

(R)-Xylyl-PHANEPhos

C48H50P2 (688.338756)


   

Trityl Olmesartan Acid

Trityl Olmesartan Acid

C43H40N6O3 (688.316173)


   

Uremic Pentapeptide (U5-Peptide)

Uremic Pentapeptide (U5-Peptide)

C32H48N8O9 (688.3544078)


   

2-ethylhexyl 6,6-dibutyl-14-ethyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadeca-2,9-dienoate

2-ethylhexyl 6,6-dibutyl-14-ethyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadeca-2,9-dienoate

C32H56O8Sn (688.2996966000001)


   

Tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene-5,11-diylbis[bis(3,5-dimethylphenyl)phosphine]

Tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene-5,11-diylbis[bis(3,5-dimethylphenyl)phosphine]

C48H50P2 (688.338756)


   

N,N-BIS(PHENANTHREN-9-YL)-N,N-DIPHENYLBENZIDINE

N,N-BIS(PHENANTHREN-9-YL)-N,N-DIPHENYLBENZIDINE

C52H36N2 (688.2878336)


   

Bis(tricyclohexylphosphine)dichloronickel

Bis(tricyclohexylphosphine)dichloronickel

C36H66Cl2NiP2 (688.3370026)


   
   
   

N4,N4-Di-1-naphthalenyl-N4,N4-di-2-naphthalenyl-[1,1-biphenyl]-4,4-diamine

N4,N4-Di-1-naphthalenyl-N4,N4-di-2-naphthalenyl-[1,1-biphenyl]-4,4-diamine

C52H36N2 (688.2878336)


   

Encequidar

Encequidar

C38H36N6O7 (688.2645345999999)


C2140 - Adjuvant

   

N,N-[2,5-O-DI-2-Fluoro-benzyl-glucaryl]-DI-[1-amino-indan-2-OL]

N,N-[2,5-O-DI-2-Fluoro-benzyl-glucaryl]-DI-[1-amino-indan-2-OL]

C38H38F2N2O8 (688.2596092000001)


   

4-[(10S,14S,18S)-18-(2-Amino-2-oxoethyl)-14-(1-naphthylmethyl)-8,17,20-trioxo-7,16,19-triazaspiro[5.14]icos-11-EN-10-YL]benzylphosphonic acid

4-[(10S,14S,18S)-18-(2-Amino-2-oxoethyl)-14-(1-naphthylmethyl)-8,17,20-trioxo-7,16,19-triazaspiro[5.14]icos-11-EN-10-YL]benzylphosphonic acid

C37H45N4O7P (688.302571)


   

Vionactane

Vionactane

C25H46N13O10+3 (688.3490436000001)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors

   

(R)-1-(threo-4-Hydroxy-L-3,6-diaminohexanoic acid)-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]viomycin

(R)-1-(threo-4-Hydroxy-L-3,6-diaminohexanoic acid)-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]viomycin

C25H46N13O10+3 (688.3490436000001)


   

Viomycin(3+)

Viomycin(3+)

C25H46N13O10+3 (688.3490436000001)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors

   

N-[[(3S,9R,10S)-16-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

N-[[(3S,9R,10S)-16-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C38H48N4O8 (688.3471968)


   
   
   
   

[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C33H52O15 (688.3306042)


   

[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C33H53O13P (688.3223618)


   

[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C33H53O13P (688.3223618)


   

[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C33H53O13P (688.3223618)


   

Viomycin(3+)

Viomycin(3+)

C25H46N13O10 (688.3490436000001)


Viomycin protonated to pH 7.3

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA)

Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA)

C28H39F3N8O9 (688.2791960000001)


Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) (Cyclo(RGDfV) (TFA))is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) can be used for the research of acute myeloid leukemia[1].

   

20,21-bis(acetyloxy)-6-(furan-3-yl)-4,12,19-trihydroxy-5,11,15,16-tetramethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate

20,21-bis(acetyloxy)-6-(furan-3-yl)-4,12,19-trihydroxy-5,11,15,16-tetramethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate

C36H48O13 (688.3094758)


   

(2s,3as,6r,7as)-n-(4-carbamimidamidobutyl)-1-[(2r)-2-{[(2r)-3-(3-chloro-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-3-methylpentanoyl]-6-(sulfooxy)-octahydroindole-2-carboximidic acid

(2s,3as,6r,7as)-n-(4-carbamimidamidobutyl)-1-[(2r)-2-{[(2r)-3-(3-chloro-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-3-methylpentanoyl]-6-(sulfooxy)-octahydroindole-2-carboximidic acid

C29H45ClN6O9S (688.2657110000001)


   

[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{4-[(2s,3r)-4-hydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2-(hydroxymethyl)butyl]-2-methoxyphenoxy}oxan-2-yl]methyl 3,4-dimethoxybenzoate

[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{4-[(2s,3r)-4-hydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2-(hydroxymethyl)butyl]-2-methoxyphenoxy}oxan-2-yl]methyl 3,4-dimethoxybenzoate

C35H44O14 (688.2730924)


   

[9a,11a-dimethyl-7,8-bis(sulfooxy)-1-(5,6,6-trimethylheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxidanesulfonic acid

[9a,11a-dimethyl-7,8-bis(sulfooxy)-1-(5,6,6-trimethylheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxidanesulfonic acid

C29H52O12S3 (688.2620751999999)


   

methyl (2s)-2-(acetyloxy)-2-[(1r,2s,5r,6s,10s,11s,12r,13s,14r,15s,17r,18r)-12,14,17-tris(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]acetate

methyl (2s)-2-(acetyloxy)-2-[(1r,2s,5r,6s,10s,11s,12r,13s,14r,15s,17r,18r)-12,14,17-tris(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]acetate

C35H44O14 (688.2730924)


   

methyl (2s)-2-(acetyloxy)-2-[(1s,2r,5r,6r,10r,11s,12r,13s,14r,15r,17s,18s)-12,14,17-tris(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]acetate

methyl (2s)-2-(acetyloxy)-2-[(1s,2r,5r,6r,10r,11s,12r,13s,14r,15r,17s,18s)-12,14,17-tris(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]acetate

C35H44O14 (688.2730924)


   

methyl 2-[(1r,2r,5r,6r,11r,12r,13r,14s,16s)-12,14-bis(acetyloxy)-6-(furan-3-yl)-13-hydroxy-11-[(isopropoxycarbonyl)oxy]-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-9-en-16-yl]acetate

methyl 2-[(1r,2r,5r,6r,11r,12r,13r,14s,16s)-12,14-bis(acetyloxy)-6-(furan-3-yl)-13-hydroxy-11-[(isopropoxycarbonyl)oxy]-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-9-en-16-yl]acetate

C35H44O14 (688.2730924)


   

n-[(3r,4s,7s,10r,15as)-5,8-dihydroxy-7,10-bis(1h-indol-3-ylmethyl)-3-methyl-1,11-dioxo-3h,4h,7h,10h,13h,14h,15h,15ah-pyrrolo[2,1-c]1-oxa-4,7,10-triazacyclotridecan-4-yl]-2-phenylethanimidic acid

n-[(3r,4s,7s,10r,15as)-5,8-dihydroxy-7,10-bis(1h-indol-3-ylmethyl)-3-methyl-1,11-dioxo-3h,4h,7h,10h,13h,14h,15h,15ah-pyrrolo[2,1-c]1-oxa-4,7,10-triazacyclotridecan-4-yl]-2-phenylethanimidic acid

C39H40N6O6 (688.3009180000001)